| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 61.728 | 60.030 | 74.110 | 94.951 | 113.351 |
| Total Income - EUR | - | - | - | - | 843 | 60.902 | 60.032 | 74.112 | 94.952 | 163.758 |
| Total Expenses - EUR | - | - | - | - | 828 | 24.716 | 35.647 | 44.377 | 59.753 | 112.849 |
| Gross Profit/Loss - EUR | - | - | - | - | 15 | 36.185 | 24.385 | 29.734 | 35.199 | 50.909 |
| Net Profit/Loss - EUR | - | - | - | - | 15 | 35.612 | 23.799 | 29.008 | 34.364 | 47.908 |
| Employees | - | - | - | - | 1 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dalimar Mitric Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 5.532 | 4.820 | 3.855 | 12.248 | 12.283 | 69.249 |
| Current Assets | - | - | - | - | 1.585 | 34.357 | 46.940 | 19.617 | 42.543 | 10.908 |
| Inventories | - | - | - | - | 1.540 | 6 | 454 | 455 | 4.240 | 3.066 |
| Receivables | - | - | - | - | 0 | 27.434 | 1.062 | 12.016 | 6.317 | 2.560 |
| Cash | - | - | - | - | 46 | 6.917 | 45.425 | 7.147 | 31.986 | 5.283 |
| Shareholders Funds | - | - | - | - | 58 | 35.668 | 23.847 | 29.057 | 51.628 | 73.245 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 7.059 | 3.509 | 26.948 | 2.808 | 3.197 | 5.736 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1.177 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dalimar Mitric Medica S.r.l.